GlaxoSmithKline, AstraZeneca, Novartis, Johnson & Johnson
– SAS announced a collaborative effort with drug giant GlaxoSmithKline aimed squarely at the global pharmaceutical industry. Forbes’ SAS and GSK Pull Big Pharma Into Big Data Collaboration explains SAS is sponsoring the ongoing support and management of a globally accessible private cloud where the pharmaceutical industry can securely collaborate around anonymized clinical trial information. GSK has made the bold commitment to be the first to contribute anonymized clinical trial data
– AstraZeneca Enters Oncology Drug Collaborations With Cambridge Partners from FirstWord Pharma reports that following the recent decision to move its UK-based global R&D center and corporate headquarters to the Cambridge Biomedical Campus, AstraZeneca announced an agreement with the University of Cambridge and Cancer Research UK to investigate tumor mutations and experimental drugs for prostate, pancreatic and potentially other cancers
– More than 21 million cases of typhoid fever and five million cases of paratyphoid A fever are reported worldwide each year. Novartis and Biological E Agree To Deliver Affordable Vaccines For Typhoid and Paratyphoid A Fevers To Developing World, highlights the agreement advancing a Novartis goal to deliver accessible and affordable vaccines that address unmet medical need in endemic regions
– Every year Fortune Magazine publishes a list of the top 50 “most admired companies” around the world. In 2012, only one pharmaceutical company made it into the top 50 and that company was Johnson & Johnson. pharmaphorum’s A History of… Johnson & Johnson looks into the creation of J&J and how it has become one of the fastest growing pharma companies in the US, Europe and Japan over the past 127 years
– GSK and Save the Children launched a $1 million Healthcare Innovation Award to identify and reward innovations in healthcare which have proven successful in reducing child deaths in developing countries. GSK and Save the Children Launch $1 Million Award To Discover New Healthcare Innovations For Reducing Child Deaths outlines the first joint initiative announced following the launch of an ambitious new partnership between GSK and Save the Children which aims to save the lives of a million of the world’s poorest children
